| Identification | Back Directory | [Name]
2-[[(4R)-4-[(3R,5S,7S,10R,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | [CAS]
64480-66-6 | [Synonyms]
GUDCA
Ursodeoxycholylglycine
Glycoursodesoxycholic acid
Glycylursodeoxycholic acid
Glycoursodeoxycholic-d4 Acid
Glycine ursodeoxycholic acid
N-[(3.α.,5.beta.,7.beta.)-3,7-Dihyd
N-[(3.alpha.,5.beta.,7.beta.)-3,7-Dihyd
N-(3α,7β-Dihydroxy-5β-cholan-24-oyl)glycine
3.α.,7.beta.-Dihydroxy-5.beta.-cholanoylglycine
N-(3α,7β-Dihydroxy-24-oxo-5β-cholan-24-yl)glycine
N-Carboxymethyl-3α,7β-dihydroxy-5β-cholan-24-amide
3.alpha.,7.beta.-Dihydroxy-5.beta.-cholanoylglycine
N-[(3α,5β,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine
N-(3.α.,7.beta.-Dihydroxy-5.beta.-cholan-24-oyl)glycine
Glycine, N-[(3a,5b,7b)-3,7-dihydroxy-24-oxocholan-24-yl]-
N-(3.alpha.,7.beta.-Dihydroxy-5.beta.-cholan-24-oyl)glycine
N-[(3.α.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl]Glycine
N-[(3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl]Glycine
3-amino-1-azabicyclo[2.2.2]oct-3-yl diphenylacetate hydrochloride(1:1)
N-((3alpha,5beta,7beta)-7-Hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl)glycine
N-[(3α,5β,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine, Glycylursodeoxycholic acid
2-[[(4R)-4-[(3R,5S,7S,10R,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C26H43NO5 | [MDL Number]
MFCD00137427 | [MOL File]
64480-66-6.mol |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
A metabolite of Ursodeoxycholic Acid, which is used as an anticholelithogenic | [Definition]
ChEBI: A bile acid glycine conjugate derived from ursoodeoxycholic acid. | [Biochem/physiol Actions]
Secondary bile acid derived from acyl glycine. Glycoursodeoxycholic Acid (GUDCA) is reported to have cytoprotective and anti-inflammatory effects. |
|
|